Why the study?
Heart failure and reduced ejection fraction is the predominant indication for CRT and ICD implantation, but the care gap and opportunity to optimize guideline-directed medical therapy is unclear.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
BACKGROUND Heart failure and reduced ejection fraction (HFrEF) is the predominant indication for cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) implantation. The care gap and opportunity to optimize guideline-directed medical therapy (GDMT) is unclear.
No takes yet. Share an insight, caveat, or question.
Salimian et al. (2021) studied this question. Guideline-directed medical therapy in patients with heart failure and cardiac implantable electronic devices presents a significant care gap and opportunity for optimization.
Synapse has enriched 10 related papers. Consider them for comparative context: